WEBINAR: Enabling Cancer Research with Echo Acoustic Liquid Handlers: a PI3K Pathway Case Study


  • 45Shares

Class I Phosphoinositide 3-kinase (PI3K) proteins have been extensively characterized with respect to their roles in cell proliferation and tumorigenesis, and serve as highly sought-after targets for oncogenic drug development. Labcyte Sr. Applications Scientist Linda Orren will present a series of experiments, all of which target some aspect of the PI3K pathway. These case studies will highlight specifics of assay development and miniaturization that are uniquely enabled by Echo Acoustic Liquid Handlers.

From dispensing reagents for orthogonal confirmatory assays to engineering plasmids with proteins of interest, the accuracy, miniaturization and cost-savings offered by Echo acoustic dispensing can be applied broadly to drug discovery and development efforts.

REGISTER NOW for this webinar, and learn more about the Echo series of liquid handlers enables workflows that go beyond traditional high-throughput screening efforts.